Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,08 USD | -6,09% | -23,94% | -6,90% |
Vakgebied
Aantal werknemers: 18
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
New Drugs and Medical Devices
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -84,28% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 23-06-23 | |
Leeds Chow
DFI | Director of Finance/CFO | 35 | 01-03-21 |
Eugene Jiang
CHM | Chairman | 38 | 01-07-15 |
Chief Tech/Sci/R&D Officer | 70 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yue Min Chung
BRD | Director/Board Member | 59 | 10-07-22 |
Shu Ling Chiang
BRD | Director/Board Member | 68 | - |
Eugene Jiang
CHM | Chairman | 38 | 01-07-15 |
Tsang Ming Jiang
BRD | Director/Board Member | 63 | 23-11-17 |
Norimi Sakamoto
BRD | Director/Board Member | 53 | 23-11-17 |
Yen-Hsin Chou
BRD | Director/Board Member | 43 | 23-11-17 |
Chief Tech/Sci/R&D Officer | 70 | - | |
Chang-Jen Jiang
BRD | Director/Board Member | 68 | - |
Yoshinobu Odaira
BRD | Director/Board Member | 76 | - |
Hsin-Hui Miao
BRD | Director/Board Member | 57 | 04-06-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 10 560 421 | 7 711 924 ( 73,03 %) | 0 | 73,03 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,90% | 11,38 mln. | |
+8,96% | 105 mld. | |
-1,43% | 104 mld. | |
+4,40% | 22,94 mld. | |
-12,15% | 22,34 mld. | |
-4,36% | 19,25 mld. | |
-39,98% | 17,08 mld. | |
-10,04% | 16,96 mld. | |
+38,61% | 12,63 mld. | |
+313,59% | 8,49 mld. |
- Beurs
- Aandelen
- Koers ABVC
- Onderneming ABVC BioPharma, Inc.